thiophenes has been researched along with Chest Pain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brar, N; Shivamurthy, P; Therrien, ML | 1 |
| Barnathan, ES; Bordes, P; Braunwald, E; Burton, P; Gibson, CM; Hricak, V; Markov, V; Mega, JL; Misselwitz, F; Mohanavelu, S; Oppenheimer, L; Poulter, R; Witkowski, A | 1 |
| Baur, X; Bittner, C | 1 |
| Rayoo, R; Sharma, N; van Gaal, WJ | 1 |
1 trial(s) available for thiophenes and Chest Pain
| Article | Year |
|---|---|
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
Topics: Acute Coronary Syndrome; Administration, Oral; Aspirin; Chest Pain; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Myocardial Infarction; Proportional Hazards Models; Pyridines; Recurrence; Risk Reduction Behavior; Rivaroxaban; Safety; Statistics, Nonparametric; Stroke; Thiophenes; Treatment Outcome | 2009 |
3 other study(ies) available for thiophenes and Chest Pain
| Article | Year |
|---|---|
Isolated hemopericardium associated with rivaroxaban: first case report.
Topics: Aged; Atrial Fibrillation; Chest Pain; Factor Xa Inhibitors; Humans; Male; Morpholines; Pericardial Effusion; Rivaroxaban; Thiophenes | 2014 |
Occupational obstructive airway diseases caused by the natural gas odorant tetrahydrothiophene--two case reports.
Topics: Aged; Arrhythmias, Cardiac; Chest Pain; Cough; Fossil Fuels; Headache; Humans; Irritants; Lung Volume Measurements; Male; Middle Aged; Mucositis; Nausea; Neurotoxicity Syndromes; Occupational Diseases; Occupational Exposure; Odorants; Protective Clothing; Pulmonary Disease, Chronic Obstructive; Thiophenes; Vomiting | 2009 |
A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim.
Topics: Acute Disease; Aspirin; Chest Pain; Clopidogrel; Eptifibatide; Female; Humans; Middle Aged; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Count; Prasugrel Hydrochloride; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Risk Factors; Stents; Thiophenes; Thrombosis; Ticlopidine; Ultrasonography, Interventional | 2012 |